» Articles » PMID: 32566095

Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing

Overview
Publisher Wiley
Date 2020 Jun 23
PMID 32566095
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent senescence seems to exert detrimental effects fostering ageing and age-related disorders, such as cancer. Chemotherapy is one of the most valuable treatments for cancer, but its clinical application is limited due to adverse side effects. Melatonin is a potent antioxidant and antiageing molecule, is nontoxic, and enhances the efficacy and reduces the side effects of chemotherapy. In this review, we first summarize the mitochondrial protective role of melatonin in the context of chemotherapeutic drug-induced toxicity. Thereafter, we tabulate the protective actions of melatonin against ageing and the harmful roles induced by chemotherapy and chemotherapeutic agents, including anthracyclines, alkylating agents, platinum, antimetabolites, mitotic inhibitors, and molecular-targeted agents. Finally, we discuss several novel directions for future research in this area. The information compiled in this review will provide a comprehensive reference for the protective activities of melatonin in the context of chemotherapy drug-induced toxicity and will contribute to the design of future studies and increase the potential of melatonin as a therapeutic agent.

Citing Articles

A bioengineered tumor matrix-based scaffold for the evaluation of melatonin efficacy on head and neck squamous cancer stem cells.

Andres J, Rodriguez-Santana C, de Lara-Pena L, Jimenez G, Escames G, Marchal J Mater Today Bio. 2024; 29:101246.

PMID: 39351489 PMC: 11440243. DOI: 10.1016/j.mtbio.2024.101246.


Antitumoral melatonin-loaded nanostructured lipid carriers.

Bonilla-Vidal L, Switalska M, Espina M, Wietrzyk J, Garcia M, Souto E Nanomedicine (Lond). 2024; 19(23):1879-1894.

PMID: 39092498 PMC: 11457606. DOI: 10.1080/17435889.2024.2379757.


The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.

Smorodin E, Chuzmarov V, Veidebaum T Curr Oncol. 2024; 31(4):1994-2023.

PMID: 38668052 PMC: 11049198. DOI: 10.3390/curroncol31040149.


Harmful Free Radicals in Aging: A Narrative Review of Their Detrimental Effects on Health.

Mustafa Y Indian J Clin Biochem. 2024; 39(2):154-167.

PMID: 38577147 PMC: 10987461. DOI: 10.1007/s12291-023-01147-y.


Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.

Al-Ansari N, Samuel S, Busselberg D Biomolecules. 2024; 14(2).

PMID: 38397382 PMC: 10886489. DOI: 10.3390/biom14020145.


References
1.
Shokrzadeh M, Chabra A, Naghshvar F, Ahmadi A, Jafarinejhad M, Hasani-Nourian Y . Protective Effects of Melatonin against Cyclophosphamide-induced Oxidative Lung Toxicity in Mice. Drug Res (Stuttg). 2014; 65(6):281-6. DOI: 10.1055/s-0034-1371801. View

2.
Jahovic N, Cevik H, Sehirli A, Yegen B, Sener G . Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res. 2003; 34(4):282-7. View

3.
Waseem M, Tabassum H, Parvez S . Neuroprotective effects of melatonin as evidenced by abrogation of oxaliplatin induced behavioral alterations, mitochondrial dysfunction and neurotoxicity in rat brain. Mitochondrion. 2016; 30:168-76. DOI: 10.1016/j.mito.2016.08.001. View

4.
Reiter R, Tan D, Rosales-Corral S, Galano A, Zhou X, Xu B . Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions. Molecules. 2018; 23(2). PMC: 6017324. DOI: 10.3390/molecules23020509. View

5.
Kolli V, Abraham P, Isaac B, Kasthuri N . Preclinical efficacy of melatonin to reduce methotrexate-induced oxidative stress and small intestinal damage in rats. Dig Dis Sci. 2012; 58(4):959-69. DOI: 10.1007/s10620-012-2437-4. View